Endogenous Glucose Production After Treatment with Canagliflozin and Liraglutide
Empagliflozin Use in People with Type 2 and History of Coronary Artery Bypass Graft Surgery (CABG)
Benefits of SGLT2 Inhibitors in Patients With or Without History of CVD
What You and Your Patient Should Know to Prevent DKA